Evidence map›Paper›PMID 41789877›Full record

ArticleDermatology reports2026

Cutaneous Rosai-Dorfman disease: a case report of disease limited only to skin.

Aurėja Kontrimienė, Emilija Šerpytienė, Monika Macejevska, Jonas Lauraitis, Jūratė Grigaitienė

Abstract read
In one paragraph

Article in Dermatology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aurėja KontrimienėDermatovenereology Department, Vilnius University Hospital Santariskiu Klinikos, Vilnius.
Emilija ŠerpytienėDermatovenereology Department, Vilnius University Hospital Santariskiu Klinikos, Vilnius.
Monika MacejevskaDermatovenereology Department, Vilnius University Hospital Santariskiu Klinikos, Vilnius.
Jonas LauraitisDermatovenereology Department, Vilnius University Hospital Santariskiu Klinikos, Vilnius.
Jūratė GrigaitienėDermatovenereology Department, Vilnius University Hospital Santariskiu Klinikos, Vilnius.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rosai-Dorfman disease (RDD) is a disorder of histiocytic proliferation that can affect almost every organ. Skin may be involved in about 10% of cases, but only 3% of patients have skin lesions exclusively. Patients with cutaneous Rosai-Dorfman disease (CRDD) are usually healthy, without leading constitutional or other symptoms. The etiology of this disease is unclear, but it might be triggered by an infectious agent such as herpesvirus 6 (HHV-6) and Epstein-Barr virus (EBV). There is also a predisposition to autoimmune diseases and hematological malignancies. There is also a recognized predisposition to autoimmune disorders and hematologic malignancies. In our case, the patient was diagnosed with an infection due to Borrelia burgdorferi. To our knowledge, no previously reported association between B. burgdorferi infection and RDD has been described. The disease may manifest in any age group. The differential diagnosis includes Langerhans cell histiocytosis, metastasis, Hodgkin's lymphoma, and other diseases. Disease usually resolves spontaneously over a period of months to years. Treatment should be administered in non-responsive or multiple relapsing cases. Also, it is very important to take into consideration the patient's expectations and aesthetic appearance before making a treatment decision. Various treatment options are described, including surgical excision, cryotherapy, corticosteroids, antibiotics, methotrexate, and dapsone. In our case, we used CO2 laser treatment successfully. To our knowledge, this is only the second case where CRDD lesions were treated successfully with CO2 laser.

Indexed as

case reportcutaneousRosai-Dorfman disease

Identifiers

PMID41789877
PMCPMC13003390

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.